Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents
{{output}}
Thienopyridines are a class of drug targeting the platelet adenosine diphosphate (ADP) 2 receptor. They significantly reduce platelet activity and are therefore clinically beneficial in settings where platelet activation is a key pathophysiological feature, pa... ...
